Study on the Anticancer Effect of an Astragaloside- and Chlorogenic Acid-Containing Herbal Medicine (RLT-03) in Breast Cancer

Figure 3

(a) Analysis of cell viability by the crystal violet assay; 4T1, BT-549, MDA-MB-231, and EMT6 cells were exposed to RLT-03 for 72 h, and cell viability was inhibited in a concentration-dependent manner. (b) 4T1, EMT6, BT-549, and MDA-MB-231 cell morphology changed, and cell death was observed after exposure to RLT-03 for 72 h.

(a)

(b)